A pilot study to evaluate renal hemodynamics in cirrhosis by simultaneous glomerular filtration rate, renal plasma flow, renal resistive indices and biomarkers measurements

American Journal of Nephrology

Volumn 39, Issue 6, 2014, Pages 543-552

  Mindikoglu, Ayse L ^a   Dowling, Thomas C ^e   Wong You Cheong, Jade J ^b   Christenson, Robert H ^c   Magder, Laurence S ^d   Hutson, William R ^a   Seliger, Stephen L ^a   Weir, Matthew R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Diagnostic Radiology and Nuclear Medicine   (United States)

^c Departments of Pathology   (United States)

^d UCSD Division of Biostatistics and Bioinformatics   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Cystatin C; End stage liver disease; Glomerular filtration rate; Kidney injury molecule 1; Neutrophil gelatinase associated lipoprotein; Renal plasma flow; Renal resistive index; Trace protein

Indexed keywords

6 N,N' DIMETHYLARGININE; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CYSTATIN C; DIURETIC AGENT; KIDNEY INJURY MOLECULE 1; N(G),N(G) DIMETHYLARGININE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; CREATININE; CST3 PROTEIN, HUMAN; HAVCR1 PROTEIN, HUMAN; ISOMERASE; LCN2 PROTEIN, HUMAN; LIPOCALIN; MEMBRANE PROTEIN; ONCOPROTEIN; PROSTAGLANDIN R2 D-ISOMERASE; VIRUS RECEPTOR; BETA TRACE PROTEIN; UNCLASSIFIED DRUG;

4 AMINOHIPPURIC ACID CLEARANCE; ADULT; ARTERIOLE; ARTICLE; ASCITES; BLOOD SAMPLING; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HEPATORENAL SYNDROME; HUMAN; HUMAN TISSUE; IMMUNOASSAY; KIDNEY; KIDNEY BLOOD FLOW; KIDNEY PLASMA FLOW; LIVER CIRRHOSIS; MALE; NEUTROPHIL; PILOT STUDY; PLASMA CLEARANCE; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VASOCONSTRICTION; AGED; BLOOD; COMPLICATION; HEMODYNAMICS; KIDNEY CIRCULATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; URINE; VASCULAR RESISTANCE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GLOMERULUS FILTRATION; KIDNEY VASCULAR RESISTANCE; RESISTIVE INDEX;

ACUTE-PHASE PROTEINS; AGED; ASCITES; BETA 2-MICROGLOBULIN; BIOMARKERS; CREATININE; CYSTATIN C; DIURETICS; FEMALE; GLOMERULAR FILTRATION RATE; HEMODYNAMICS; HEPATORENAL SYNDROME; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; LIPOCALINS; LIVER CIRRHOSIS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PILOT PROJECTS; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS; RENAL CIRCULATION; RENAL PLASMA FLOW; SEVERITY OF ILLNESS INDEX; VASCULAR RESISTANCE;

EID: 84902301302     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000363584     Document Type: Article

References (41)

1. Garcia-Tsao G, Parikh CR, Viola A: Acute kidney injury in cirrhosis. Hepatology 2008; 48: 2064-2077.
2. Gines P: Pharmacological management of hepatorenal syndrome: lessons from non-responders. J Hepatol 2011; 55: 268-269.
3. Gluud LL, Christensen K, Christensen E, Krag A: Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome. Hepatology 2010; 51: 576-584.
4. Cholongitas E, Senzolo M, Patch D, Shaw S, O'Beirne J, Burroughs AK: Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality. Eur J Gastroenterol Hepatol 2009; 21: 744-750.
5. Wong F, Nadim MK, Kellum JA, et al: Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut 2011; 60: 702-709.
6. Alessandria C, Ozdogan O, Guevara M, et al: MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology 2005; 41: 1282-1289. (Pubitemid 40770280)
7. Epstein M: Hepatorenal syndrome: emerging perspectives of pathophysiology and therapy. J Am Soc Nephrol 1994; 4: 1735-1753.
8. Epstein M, Berk DP, Hollenberg NK, et al: Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med 1970; 49: 175-185.
9. Epstein M, Schneider N, Befeler B: Relationship of systemic and intrarenal hemodynamics in cirrhosis. J Lab Clin Med 1977; 89: 1175-1187. (Pubitemid 8130190)
10. Data. Available at http://optn.transplant.hrsa.gov/latestData/rptData. asp. Accessed February 28, 2014.
11. Mindikoglu AL, Weir MR: Current concepts in the diagnosis and classification of renal dysfunction in cirrhosis. Am J Nephrol 2013; 38: 345-354.
12. Sherman DS, Fish DN, Teitelbaum I: Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis 2003; 41: 269-278. (Pubitemid 36152445)
13. Kew MC, Brunt PW, Varma RR, Hourigan KJ, Williams HS, Sherlock S: Renal and intrarenal blood flow in cirrhosis of the liver. Lancet 1971; 2: 504-510.
14. Salerno F, Gerbes A, Gines P, Wong F, Arroyo V: Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 2007; 56: 1310-1318. (Pubitemid 47300435)
15. Wang DJ, Dowling TC, Meadows D, et al: Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation 2004; 110: 1620-1625. (Pubitemid 39297985)
16. Levey AS, Coresh J, Greene T, et al: Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007; 53: 766-772. (Pubitemid 46580250)
17. Dowling TC, Frye RF, Zemaitis MA: Simultaneous determination of p -aminohippuric acid, acetyl- p -aminohippuric acid and iothalamate in human plasma and urine by highperformance liquid chromatography. J Chromatogr B Biomed Sci Appl 1998; 716: 305-313. (Pubitemid 28464576)
18. Mindikoglu AL, Dowling TC, Weir MR, Seliger SL, Christenson RH, Magder LS: Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis. Hepatology 2014; 59: 1532-1542.
19. Gibaldi M, Perrier D: Pharmacokinetics, ed 2. New York, Dekker, 1982.
20. Viazzi F, Leoncini G, Derchi LE, Pontremoli R: Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient. J Hypertens 2014; 32: 149-153.
21. SDMA-ELISA: Available at http://www.dlddiagnostika.de/uploads/SDMA-E.pdf. Accessed September 21, 2009.
22. ADMA-Arginine-Plasma ELISA. Available http://www.dld-diagnostika.de/ uploads/ADMA-Arginine-Plasma-E.pdf. Accessed March 27, 2012.
23. Renin Human ELISA. Available at http://www.biovendor.com/product/ immunoassays/renin-human-elisa. Accessed January 8, 2014.
24. Aldosterone ELISA. Available at http://www.biovendor.com/product/ immunoassays/aldosterone-elisa. Accessed January 8, 2014.
25. Package Insert/Instructions for Use, CYSC, REF K7040, Issue date 2011-03, Siemens, Dimension Vista ® System Flex ® reagent cartridge. Siemens Healthcare Diagnostics, Inc., Newark, USA).
26. Package Insert/Instructions for Use, ECREA, REF K1270A, Issue date 2012-04-04, Siemens, Dimension Vista ® System Flex ® reagent cartridge. Siemens Healthcare Diagnostics, Inc., Newark, USA.
27. Package Insert/Instructions for Use, B2MIC, REF K7024, Issue date 2009-05, Siemens, Dimension Vista ® System Flex ® reagent cartridge. Siemens Healthcare Diagnostics, Inc., Newark, USA.
28. Package Insert/Instructions for Use, N Latex βTP. Siemens Healthcare Diagnostics, Inc., Newark, USA.
29. Quantikine ® ELISA. Human Lipocalin-2/ NGAL Immunoassay. Available at http://www.rndsystems.com/pdf/DLCN20.pdf. Accessed January 8, 2014.
30. Human KIM-1 Elisa Kit. Available at http://www.aviscerabioscience.com/ Product-Systems/KIM-1/SK00186-01-avbs.pdf. Accessed January 8, 2014.
31. SAS software: http://www.sas.com/. The data analysis for this paper was generated using SAS software, version 9.2 of the SAS System for Windows. Copyright 2002-2008 SAS Institute Inc. SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc., Cary, USA.
32. Minitab 15 Statistical Software (2007) (Computer software). State College, Minitab, Inc. (www.minitab.com).
33. Belcher JM, Sanyal AJ, Peixoto AJ, et al: Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology 2013, Epub ahead of print.
34. The History of Poiseuille's Law. Available at http://www.annualreviews. org/doi/pdf/10.1146/annurev.fl.25.010193.000245. Accessed January 15, 2014.
35. Tublin ME, Tessler FN, Murphy ME: Correlation between renal vascular resistance, pulse pressure, and the resistive index in isolated perfused rabbit kidneys. Radiology 1999; 213: 258-264. (Pubitemid 29470435)
36. Leslie SH, Johnston B, Ralli EP: Renal function as a factor in fluid retention in patients with cirrhosis of the liver. J Clin Invest 1951; 30: 1200-1207.
37. Koeppen BM, Stanton BA: Glomerular filtration and renal blood flow; in Koeppen BM, Stanton BA (eds): Renal Physiology, ed 4. Philadelphia, Mosby, 2007, pp 31-46.
38. Hall JE: Urine formation by the kidneys; in Hall JE, Guyton A (eds): Guyton and Hall Textbook of Medical Physiology, ed 11. Philadelphia, Saunders/Elsevier, 2011, pp 303-322.
39. Bossard G, Bourgoin P, Corbeau JJ, Huntzinger J, Beydon L: Early detection of postoperative acute kidney injury by Doppler renal resistive index in cardiac surgery with cardiopulmonary bypass. Br J Anaesth 2011; 107: 891-898.
40. Knapp R, Plotzeneder A, Frauscher F, et al: Variability of Doppler parameters in the healthy kidney: an anatomic-physiologic correlation. J Ultrasound Med 1995; 14: 427-429.
41. Rivolta R, Maggi A, Cazzaniga M, et al: Reduction of renal cortical blood flow assessed by Doppler in cirrhotic patients with refractory ascites. Hepatology 1998; 28: 1235-1240. (Pubitemid 28493832)